Skip to main content
. 2010 Jul;15(3):304–311. doi: 10.1111/j.1369-1600.2010.00216.x

Figure 2.

Figure 2

Effects of daily peripheral treatment with a selective growth hormone secretagogue receptor 1A (GHS-R1A) antagonist (JMV2959) (12 mg/kg) to rats on (a) body weight gain; (b) cumulative chow intake; (c) intake of Ensure®; and (d) preference for Ensure®. n = 5–6 per group, a–c **P < 0.01, repeated-measures two-way analysis of variance, d *P < 0.05, Student's t-test